Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

Published Date: 15 Jan 2024

A dose of 70 Gy divided into 15 fractions demonstrated a good balance between safety and effectiveness in a small trial.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

2.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

3.

Best foot forward—chemo care should include podiatry, say researchers

4.

Telemedicine services linked to reducing excess mortality

5.

Inner Thoughts of Leonard Bernstein, the "Maestro".


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot